<p>(A–C) HPLC chromatograms. (A) Standard BBR; (B) Blank sample from BBR treated cells; (C) Samples from cells with BBR administration for 12 h. (D) Standard curves of BBR concentration verse AU intensity using HPLC assay. (E–G) Kinetic behavior of BBR in the cells in plot with the administration time in 24 h. (E) HepG2; (F) HeLa; (G) SY5Y cells. (H, I) LC/MS chromatograms of BBR in HepG2 cells after the administration for 24 h. (H) the mass spectrum of BBR; (I) the chromatogram of BBR. Standard BBR was shown in green; the sample was shown in purple color. Data are presented as mean ± S.D. from six independent experiments (n = 6).</p
<p><b>(A)</b> Western blotting of LC3B in HEK293 cells transfected with or without Htt and treated w...
<p>Hoechst33342, TO-PRO-3, and TMRM were used to characterize the untreated HepG2 population and the...
<p>3A Profiles of BBR and its metabolites in liver distribution in SD rats after oral administration...
<p>1A Structure of BBR 1B Mass spectrographic behavior of BBR 1C Representative EIC chromatogram of ...
<p>Chromatograms of (A) blank serum (B) blank serum spiked with (1) d6-BBR (31.25 ng/mL) and (2) BBR...
<p>(A–I) Images of the subcellular location of BBR in cells before and after 0.5 µg/ml BBR administr...
<p>(A) (from I to V) depicts images of the subcellular location of BBR in PC12 cells one hour after ...
<p>Concentration of BBR and its metabolites (M1, M2, M3, M4) in HFD rat liver and plasma (Mean ± SEM...
<p>Cells were treated with 0.5 µg/ml BBR and 0.3 µmol Zosuquidar, the inhibitor of P-gp activity, fo...
<p><b>(A)</b> Immunocytostaining images (10 X) of Htt-120Q- or Htt-20Q-transfected HEK293 cells that...
<p>A) Plasma concentration time profile of BBR free drug and BBR-SD formulation in Sprague Dawley ra...
<p>(A) represents the cytotoxicity of BBR from the MTT assay: A(I) and A(II) represent the cytotoxic...
<p>Effect of BBR and BC-HDD on cells treated with glucose. Results expressed as the % of sub-G1 popu...
<p>(A) BBR decreased oxygen consumption in H4IIE hepatocytes. The cells were plated in DMEM culture ...
<p>BaP (A), 3OH (B), t7,8 (C) and Pyr (D) profiles in cells. A549 cells were incubated with BSA (car...
<p><b>(A)</b> Western blotting of LC3B in HEK293 cells transfected with or without Htt and treated w...
<p>Hoechst33342, TO-PRO-3, and TMRM were used to characterize the untreated HepG2 population and the...
<p>3A Profiles of BBR and its metabolites in liver distribution in SD rats after oral administration...
<p>1A Structure of BBR 1B Mass spectrographic behavior of BBR 1C Representative EIC chromatogram of ...
<p>Chromatograms of (A) blank serum (B) blank serum spiked with (1) d6-BBR (31.25 ng/mL) and (2) BBR...
<p>(A–I) Images of the subcellular location of BBR in cells before and after 0.5 µg/ml BBR administr...
<p>(A) (from I to V) depicts images of the subcellular location of BBR in PC12 cells one hour after ...
<p>Concentration of BBR and its metabolites (M1, M2, M3, M4) in HFD rat liver and plasma (Mean ± SEM...
<p>Cells were treated with 0.5 µg/ml BBR and 0.3 µmol Zosuquidar, the inhibitor of P-gp activity, fo...
<p><b>(A)</b> Immunocytostaining images (10 X) of Htt-120Q- or Htt-20Q-transfected HEK293 cells that...
<p>A) Plasma concentration time profile of BBR free drug and BBR-SD formulation in Sprague Dawley ra...
<p>(A) represents the cytotoxicity of BBR from the MTT assay: A(I) and A(II) represent the cytotoxic...
<p>Effect of BBR and BC-HDD on cells treated with glucose. Results expressed as the % of sub-G1 popu...
<p>(A) BBR decreased oxygen consumption in H4IIE hepatocytes. The cells were plated in DMEM culture ...
<p>BaP (A), 3OH (B), t7,8 (C) and Pyr (D) profiles in cells. A549 cells were incubated with BSA (car...
<p><b>(A)</b> Western blotting of LC3B in HEK293 cells transfected with or without Htt and treated w...
<p>Hoechst33342, TO-PRO-3, and TMRM were used to characterize the untreated HepG2 population and the...
<p>3A Profiles of BBR and its metabolites in liver distribution in SD rats after oral administration...